Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro costs vary depending on the dose and provider, but in the UK's private market monthly prices typically range from around £149 to £375. That range widened significantly after Eli Lilly raised its list price on 1 September 2025, with the highest-dose pen's list price rising from around £122 to around £330. Mounjaro is a prescription-only medicine, which means the cost you see should always include a genuine clinical assessment by a qualified prescriber — not just the pen itself. What you pay, and what that payment covers, differs considerably between providers, and understanding those differences matters more than finding the lowest headline figure.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is that different providers bundle different things into their headline price. Some quote the cost of the pen and add consultation fees, prescription charges and delivery on top. Others include everything in one figure. Because Mounjaro is a prescription-only medicine regulated under the Human Medicines Regulations 2012, any lawful supply must follow a clinical assessment by a qualified prescriber, so that step is never optional, even if it isn't always visible in the advertised price.
Dose also plays a significant role. Mounjaro comes in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Treatment always begins at 2.5 mg (a lower starting strength designed to give your body time to adjust) and is titrated upward by the prescriber over several months. Higher doses carry a higher wholesale cost, so the price you pay can change as your treatment progresses. For a fuller picture of how the titration schedule works, the tirzepatide overview on this site sets out the clinical background in plain terms.
It is worth reading the Mounjaro price comparison guide before committing to any provider, it breaks down what different services typically include and what questions to ask.
In August 2025, Eli Lilly announced it would raise Mounjaro's UK list price from 1 September 2025. The most visible change was at the top of the dose range: the 15 mg pen's list price moved from around £122 to around £330. Lower doses saw smaller increases, but the effect rippled through the private market because providers purchase stock through the licensed UK supply chain at revised wholesale rates.
As widely reported at the time, private monthly prices since then have typically sat between roughly £149 and £375, depending on which dose you are taking and which service you use. These are market-range figures, not fixed tariffs, individual providers set their own pricing within that landscape. The NHS England guidance on weight management injections gives useful context on what a medically sound treatment programme should involve, regardless of whether you access it publicly or privately.
One practical note: if you are planning a first order around a bank holiday, or your payday falls at the end of the month, it is worth factoring in that same-day dispatch depends on orders placed before 12pm on working days, holidays pause that clock. It is also sensible to read about what happens if you take too much Mounjaro, so you feel confident handling your doses safely from the start.
This is the question most people forget to ask. A compliant, clinically safe Mounjaro price should cover: a consultation assessed by a GPhC-registered prescriber (not a questionnaire reviewed by software); a valid UK prescription; dispensing from a pharmacy you can verify on the GPhC register; and delivery. Some services charge separately for one or more of these. Others include aftercare (clinical follow-up between orders) and others do not.
At nume, one transparent price covers the consultation, prescription, treatment and free next-working-day DPD delivery. There are no subscription commitments and no hidden fees. A GPhC-registered Independent Prescriber personally reviews every consultation the same day it is submitted. That is not the cheapest model to operate, and it is not meant to be. For a prescription medicine, safety and clinical oversight are the right benchmarks, not the lowest per-pen price.
If you would like to understand what the treatment could realistically achieve, the evidence on how much weight people lose on Mounjaro draws on the SURMOUNT trial data published in the New England Journal of Medicine.
Yes. The MHRA has issued public warnings about fake weight-loss pens sold online and through social media, some containing insulin rather than tirzepatide, and some leading to hospitalisations. In 2025 alone, enforcement actions resulted in the seizure of around 20 million doses of illegally traded weight-loss medicines (approximately £45 million street value), and the first UK site manufacturing counterfeit tirzepatide pens was raided. Sellers offering Mounjaro without a valid prescription, at prices well below the market range, or with promotional codes from unverified sources, are consistent with the risk patterns the MHRA has described. You can report a suspect seller at yellowcard.mhra.gov.uk.
nume does not operate discount codes or promotional offers of any kind. The Mounjaro treatment page shows current pricing transparently. If you want to understand whether treatment is clinically appropriate for you, the eligibility criteria page explains what the licensed requirements look like in practice. When you are ready, you can check your eligibility through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.